PE-conjugated Anti-LIV-1(ladiratuzumab biosimilar) mAb

Price: 100 test ￥1360.00

SKU: BME100113P Category: Biosimilar reference antibodies

Uniprot ID	Q13433
Common Name	hLIV22
Synonyms	LIV1;SLC39A6;ZIP-6
Applications	Flow Cyt
Recommended Dilutions	Flow Cyt 1:100
Formulation & Reconstitution	Liquid，PBS with 0.05% Proclin300, 1% BSA
Host Species	Humanized
IgG type	IgG1
Reactivity	Human
Target	LIV-1
Description	PE-conjugated Anti-LIV-1(ladiratuzumab biosimilar) mAb
Delivery	3-4 weeks
Storage & Shipping	Store at 2°C-8°C for 6 months
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Usage	Research use only
Conjugate	PE-conjugated
DIMA Disclaimer	All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement.